E2	Age:T2 Numeric-Filter:E3
E3	Eq-Comparison:T3 Value:T51 Operator:T52 Value:T53 Temporal-Unit:T54
E4	Observation:T4 Name:T55 Numeric-Filter:E5
E5	Eq-Comparison:T5 Value:T56 Operator:T57 Value:T58 Unit:T59 Per:T60
E6	Eq-Comparison:T6 Temporal-Period:T61
E7	Condition:T7 Name:T62 Temporality:E6
E8	Eq-Comparison:T8 Temporal-Period:T63
E9	Condition:T9 Name:T64 Temporality:E8
E10	Condition:T10 Name:T65 Temporality:E8
E12	Condition:T12 Name:T66 Temporality:E8
E13	Eq-Comparison:T13 Temporal-Period:T67
E14	Condition:T14 Name:T68 Temporality:E13
E15	Condition:T15 Name:T69
E17	Assertion:T17 Asserted:E18
E18	Condition:T18 Name:T70
E19	Modifier:T19 Modifies:T70
E20	Condition:T20 Name:T71
E21	Eq-Comparison:T21 Temporal-Period:T72
E22	Drug:T22 Name:T73 Temporality:E21
E24	Drug:T24 Name:T74 Temporality:E21
E25	Condition:T25 Name:T75 Temporality:E52
E27	Condition:T27 Name:T76 Temporality:E52
E28	Condition:T28 Name:T77
E29	Eq-Comparison:T29 Temporal-Period:T78
E30	Drug:T30 Name:T79 Temporality:E29
E31	Modifier:T31 Modifies:E33
E33	Condition:T33 Stability:T98 Name:T80
E34	Drug:T34 Stability:T81 Temporality:E35
E35	Eq-Comparison:T35 Temporal-Period:T82 Temporal-Unit:T83
E36	Condition:T36 Name:T84
E37	Drug:T37 Name:T100
E40	Eq-Comparison:T40 Temporal-Period:T85
E42	Eq-Comparison:T42 Temporal-Period:T86
E44	Eq-Comparison:T44 Operator:T87 Temporal-Period:T88 Value:T89 Temporal-Unit:T90
E45	Condition:T45 Name:T91
E48	Modifier:T48 Modifies:T91
E49	Modifier:T93 Modifies:T70
E51	Modifier:T95 Modifies:T71
E52	Eq-Comparison:T96 Temporal-Period:T97
E53	Modifier:T99 Modifies:E33
E39	Coreference:T39 Refers-To:E37
E43	Coreference:T43 Refers-To:E37 Temporality:E40 Temporality2:E42 Temporality3:E44
E46	Modifier:T46 Modifies:T91
E47	Modifier:T47 Modifies:T91
T2	Age 40 44	aged
T3	Eq-Comparison 45 59	18 to 60 years
T4	Observation 66 81	Body mass index
T5	Eq-Comparison 82 96	20 to 27 kg/m2
T6	Eq-Comparison 136 142	active
T7	Condition 143 169	inflammatory bowel disease
T8	Eq-Comparison 189 201	pre-existing
T9	Condition 202 216	Celiac disease
T10	Condition 218 251	exocrine pancreatic insufficiency
T12	Condition 255 280	small bowel malabsorption
T13	Eq-Comparison 300 306	active
T14	Condition 307 323	bowel malignancy
T15	Condition 343 360	diabetes mellitus
T17	Assertion 371 380	suspected
T18	Condition 381 399	motility disorders
T19	Modifier 407 410	gut
T20	Condition 444 457	liver disease
T21	Eq-Comparison 472 474	on
T22	Drug 475 484	ezetimibe
T24	Drug 488 510	bile acid sequestrants
T25	Condition 533 541	pregnant
T27	Condition 545 558	breastfeeding
T28	Condition 579 592	renal disease
T29	Eq-Comparison 608 610	on
T30	Drug 611 625	benzodiazepine
T31	Modifier 641 648	cardiac
T33	Condition 664 671	disease
T34	Drug 692 702	medication
T35	Eq-Comparison 710 725	preceding month
T36	Condition 745 759	hypersensitive
T37	Drug 763 772	Revestive
T40	Eq-Comparison 792 798	active
T42	Eq-Comparison 804 811	history
T44	Eq-Comparison 824 847	within the last 5 years
T45	Condition 867 880	GI malignancy
T48	Modifier 907 917	pancreatic
T49	Life-Stage-And-Gender 25 28	Men
T50	Life-Stage-And-Gender 33 38	women
T51	Eq-Value 45 47	18
T52	Eq-Operator 48 50	to
T53	Eq-Value 51 53	60
T54	Eq-Temporal-Unit 54 59	years
T55	Observation-Name 66 81	Body mass index
T56	Eq-Value 82 84	20
T57	Eq-Operator 85 87	to
T58	Eq-Value 88 90	27
T59	Eq-Unit 91 93	kg
T60	Eq-Unit 94 96	m2
T61	Eq-Temporal-Period 136 142	active
T62	Condition-Name 143 169	inflammatory bowel disease
T63	Eq-Temporal-Period 189 201	pre-existing
T64	Condition-Name 202 216	Celiac disease
T65	Condition-Name 218 251	exocrine pancreatic insufficiency
T66	Condition-Name 255 280	small bowel malabsorption
T67	Eq-Temporal-Period 300 306	active
T68	Condition-Name 307 323	bowel malignancy
T69	Condition-Name 343 360	diabetes mellitus
T70	Condition-Name 381 399	motility disorders
T71	Condition-Name 444 457	liver disease
T72	Eq-Temporal-Period 472 474	on
T73	Drug-Name 475 484	ezetimibe
T74	Drug-Name 488 510	bile acid sequestrants
T75	Condition-Name 533 541	pregnant
T76	Condition-Name 545 558	breastfeeding
T77	Condition-Name 579 592	renal disease
T78	Eq-Temporal-Period 608 610	on
T79	Drug-Name 611 625	benzodiazepine
T80	Condition-Name 664 671	disease
T81	Stability 681 688	changes
T82	Eq-Temporal-Period 710 719	preceding
T83	Eq-Temporal-Unit 720 725	month
T85	Eq-Temporal-Period 792 798	active
T86	Eq-Temporal-Period 804 811	history
T87	Eq-Operator 824 830	within
T88	Eq-Temporal-Period 835 839	last
T89	Eq-Value 840 841	5
T90	Eq-Temporal-Unit 842 847	years
T91	Condition-Name 867 880	GI malignancy
T93	Modifier 364 369	known
T95	Modifier 430 443	decompensated
T96	Eq-Comparison 529 532	are
T97	Eq-Temporal-Period 529 532	are
T98	Stability 632 640	Unstable
T99	Modifier 652 663	respiratory
T100	Drug-Name 763 772	Revestive
T39	Coreference 780 790	ingredient
T84	Condition-Name 745 759	hypersensitive
T43	Coreference 815 823	the drug
T46	Modifier 882 890	GI tract
T47	Modifier 892 905	hepatobiliary
A1	Assertion-Type-Value E17 possible
A2	Life-Stage-And-Gender-Type T49 male
A3	Life-Stage-And-Gender-Type T50 female
A4	Eq-Operator-Value T52 BETWEEN
A5	Eq-Temporal-Unit-Value T54 year
A6	Observation-Type-Value E4 vital
A7	Eq-Operator-Value T57 BETWEEN
A8	Eq-Temporal-Period-Value T61 present
A9	Eq-Temporal-Period-Value T63 past
A10	Eq-Temporal-Period-Value T67 present
A11	Eq-Temporal-Period-Value T72 present
A12	Eq-Temporal-Period-Value T78 present
A13	Stability-Value T81 change
A14	Eq-Temporal-Period-Value T82 past
A15	Eq-Temporal-Unit-Value T83 month
A16	Eq-Temporal-Period-Value T85 present
A17	Eq-Temporal-Period-Value T86 past
A18	Eq-Operator-Value T87 LTEQ
A19	Eq-Temporal-Period-Value T88 past
A20	Eq-Temporal-Unit-Value T90 year
A21	Eq-Temporal-Period-Value T97 present
A22	Stability-Value T98 change
R1	Caused-By Arg1:E36 Arg2:E37
R2	Caused-By Arg1:E36 Arg2:E39
R3	Or Arg1:T49 Arg2:T50
R4	Or Arg1:E10 Arg2:E12
R5	Or Arg1:E15 Arg2:E18
R6	Or Arg1:E22 Arg2:E24
R7	Or Arg1:E25 Arg2:E27
R8	Or Arg1:E31 Arg2:E53
R9	Or Arg1:E37 Arg2:E39
R10	Or Arg1:E40 Arg2:E42
R11	Or Arg1:E49 Arg2:E17
R12	Or Arg1:E9 Arg2:E10
R13	Or Arg1:E46 Arg2:E47
R14	Or Arg1:E47 Arg2:E48
